Cargando…

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer

BACKGROUND AND OBJECTIVES: Patients with muscle-invasive bladder cancer (MIBC) often experience a waiting period before radical surgery for numerous reasons; however, the COVID-19 outbreak has exacerbated this problem. Therefore, it is necessary to discuss the impact of the unavoidable time of surgi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuaishuai, Chen, Rui, Raj, Ashok, Xue, Ning, Zhao, Fangzheng, Shen, Xihao, Peng, Yunpeng, Zhu, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773555/ https://www.ncbi.nlm.nih.gov/pubmed/36568226 http://dx.doi.org/10.3389/fonc.2022.1001843

Ejemplares similares

Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis
por: Zhao, Fangzheng, et al.
Publicado: (2021)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
por: Li, Shuaishuai, et al.
Publicado: (2022)

Preoperative Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Potential Recurrence Risk in NMIBC
por: Li, Shuaishuai, et al.
Publicado: (2022)

Efficacy and safety of photodynamic therapy for non–muscle-invasive bladder cancer: a systematic review and meta-analysis
por: Li, Haitao, et al.
Publicado: (2023)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2020)

Muscle-invasive angiosarcoma of the urinary bladder: Case report
por: Madiraju, Srigita, et al.
Publicado: (2023)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma
por: Barnett, Jack, et al.
Publicado: (2020)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
por: Su, Fei, et al.
Publicado: (2022)

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022)

Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Higher Stage in Urothelial Carcinoma
por: Zhao, Fangzheng, et al.
Publicado: (2022)

Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature
por: Wu, Jie, et al.
Publicado: (2022)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
por: Annels, Nicola E., et al.
Publicado: (2020)

Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
por: Deng, Sheng, et al.
Publicado: (2022)

Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective
por: Yang, Yongjun, et al.
Publicado: (2023)

Pyeloduodenal fistula complicating neoadjuvant chemotherapy in a patient diagnosed with muscle invasive bladder cancer
por: Alanee, Shaheen
Publicado: (2019)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer
por: Zhang, Jinghua, et al.
Publicado: (2021)

The role of radiomics with machine learning in the prediction of muscle-invasive bladder cancer: A mini review
por: Huang, Xiaodan, et al.
Publicado: (2022)

Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients
por: Zhao, Yi, et al.
Publicado: (2023)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS
por: Plambeck, Benjamin D., et al.
Publicado: (2023)

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
por: Del Bene, Gabriella, et al.
Publicado: (2018)

Knowledge of and Compliance With Guidelines in the Management of Non-Muscle-Invasive Bladder Cancer: A Survey of Chinese Urologists
por: Wang, Dan-Qi, et al.
Publicado: (2021)

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
por: Burley, Amy, et al.
Publicado: (2022)

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
por: Du, Zheng, et al.
Publicado: (2022)

CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer
por: Chen, Weitian, et al.
Publicado: (2022)

Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
por: Grabe-Heyne, Kristin, et al.
Publicado: (2023)

Deep learning in bladder cancer imaging: A review
por: Li, Mingyang, et al.
Publicado: (2022)

Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans
por: Knapp, Deborah W., et al.
Publicado: (2020)

Surgical management for giant bladder leiomyosarcoma
por: Hart, Alexander A., et al.
Publicado: (2022)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)

Advances in surgical management of muscle invasive bladder cancer
por: Kukreja, Janet Baack, et al.
Publicado: (2017)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
por: Liu, Kang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u6ksqqsstgtaib40l5icmec9vg